| Dr James P Mccormick, MD | |
|
121 Medical Center Drive, Suite 3300, Brunswick, ME 04011 | |
| (207) 373-6490 | |
| (207) 373-6491 |
| Full Name | Dr James P Mccormick |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 121 Medical Center Drive, Brunswick, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801999024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 016158 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mid Coast Hospital | Brunswick, ME | Hospital |
| Stephens Memorial Hospital | Norway, ME | Hospital |
| Lincolnhealth | Damariscotta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
Parenting a teenage athlete is a juggling act—monitoring homework, keeping up with practice and training schedules, weeks packed with competitions or games. It may seem like a never-ending "to do" list and that yearly sports physical can seems like just one more thing in a busy parent's life. But the quickest way of checking if off the list could be detrimental to a teen's health.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
A team of scientists from the USA and Israel has recently highlighted the importance of a third booster dose of the Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in achieving additional protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server.
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
› Verified 3 days ago
| Entity Name | Mid Coast Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932164795 PECOS PAC ID: 5496739468 Enrollment ID: O20040623001212 |
News Archive
Parenting a teenage athlete is a juggling act—monitoring homework, keeping up with practice and training schedules, weeks packed with competitions or games. It may seem like a never-ending "to do" list and that yearly sports physical can seems like just one more thing in a busy parent's life. But the quickest way of checking if off the list could be detrimental to a teen's health.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
A team of scientists from the USA and Israel has recently highlighted the importance of a third booster dose of the Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in achieving additional protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server.
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
› Verified 3 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Parenting a teenage athlete is a juggling act—monitoring homework, keeping up with practice and training schedules, weeks packed with competitions or games. It may seem like a never-ending "to do" list and that yearly sports physical can seems like just one more thing in a busy parent's life. But the quickest way of checking if off the list could be detrimental to a teen's health.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
A team of scientists from the USA and Israel has recently highlighted the importance of a third booster dose of the Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in achieving additional protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server.
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James P Mccormick, MD 121 Medical Center Dr, Suite 3300, Brunswick, ME 04011-2653 Ph: (207) 373-6490 | Dr James P Mccormick, MD 121 Medical Center Drive, Suite 3300, Brunswick, ME 04011 Ph: (207) 373-6490 |
News Archive
Parenting a teenage athlete is a juggling act—monitoring homework, keeping up with practice and training schedules, weeks packed with competitions or games. It may seem like a never-ending "to do" list and that yearly sports physical can seems like just one more thing in a busy parent's life. But the quickest way of checking if off the list could be detrimental to a teen's health.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
A team of scientists from the USA and Israel has recently highlighted the importance of a third booster dose of the Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in achieving additional protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server.
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting.
› Verified 3 days ago
George Richard Polkinghorn, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 81 Medical Center Dr, Suite 1300, Brunswick, ME 04011 Phone: 207-729-1148 Fax: 207-729-2789 | |
Miguel R Arguedas - Brollo, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Suite 3400, Brunswick, ME 04011 Phone: 207-406-7300 Fax: 207-406-7301 | |
Dr. Peter Westervelt, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 329 Maine St, Brunswick, ME 04011 Phone: 207-373-2266 Fax: 314-454-5902 | |
Dr. Thomas Blake Hendrix, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Jeremy Leonard Hardison, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Brunswick, ME 04011 Phone: 207-661-2018 | |
Deanna L Pouliot, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Dr. Timothy R Howe, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 329 Maine St, Suite D, Brunswick, ME 04011 Phone: 207-725-2429 Fax: 207-721-9345 |